Clinical trials
Neurological Diseases or Conditions clinical trials
Below are recruiting neurological diseases or conditions clinical trials, each written for real people, not researchers. We’re tracking 4,615 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07182058RecruitingPhase 1/Phase 2
Brain stimulation device for Parkinson's motor symptoms
This trial tests a wearable brain stimulation device (tES) that delivers gentle electrical currents to your head to help improve Parkinson's motor symptoms like tremor, stiffness, or slowness. The treatment is done at home with remote video monitoring, and may offer a non-medication option to help with movement.
Cleveland, OhioAges 18–80 - NCT07182422RecruitingPhase 4
AST-120 for kidney protection after acute kidney injury
This trial tests if the drug AST-120 (Kremezin) can help protect your kidneys and slow down further kidney decline after a recent acute kidney injury. It is for people who had a moderate to severe kidney injury during a hospital stay and now have mild to moderate chronic kidney damage.
TaoyuanAges 18–80 - NCT07182474Recruiting
Turkish version of a baby neurological exam
This study is testing a Turkish version of a brief exam for babies with a high risk of cerebral palsy (CP). The goal is to see if the exam can help doctors spot brain development problems early, so your baby can get the right support sooner.
Kahramanmaraş, OnikişubatAges 3 months–1 year - NCT07184944RecruitingPhase 3
Study of Duvakitug for moderate to severe Crohn's disease
This study tests a new drug called duvakitug to see if it can help maintain improvement in people with moderate to severe Crohn's disease. It's for patients who have already responded to treatment in a previous study.
Colorado Springs, ColoradoAges 16–80 - NCT07187167RecruitingPhase 2
Lenalidomide and dexamethasone for Rosai-Dorfman disease
This trial tests a combination of two drugs, lenalidomide and dexamethasone (called the RD regimen), for people with Rosai-Dorfman disease, a rare disorder that causes immune cells to build up in the body. Researchers want to see if this treatment is safe and effective for patients who are newly diagnosed or whose disease has come back or not improved with other treatments.
BeijingAges 18–80 - NCT07190404Recruiting
Thinking skills program for Parkinson's disease
This study tests a program to help people with Parkinson's disease who are noticing problems with their memory or thinking. The program teaches strategies to manage daily thinking challenges.
St Louis, MissouriAges 50 years+ - NCT07191951Recruiting
Adrenal disease study at Shanghai hospital
This study is building a medical database for people with adrenal gland problems like Cushing's syndrome or adrenal tumors. It may help doctors understand these conditions better and improve future care.
ShanghaiAges 18–75 - NCT07192705Recruiting
NTM lung disease vs. bronchiectasis health impact study
This study compares the health of people with NTM lung disease (not on antibiotics) to people with bronchiectasis (who have never had NTM infection). It aims to understand how these conditions affect daily life.
LondonAges 18 years+ - NCT07194590RecruitingPhase 2
Equol and blood vessel health in women with kidney disease
This trial tests whether a supplement called equol, made from soy, can improve blood vessel function in postmenopausal women with moderate to advanced chronic kidney disease. Participants take equol or a placebo for several weeks to see if it helps their heart health.
Aurora, ColoradoAges 50 years+ - NCT07199998Recruiting
How tampons and cups affect your vaginal health
This study looks at how tampons and menstrual cups affect your body's natural defenses and the healthy bacteria in your vagina. You might join if you are a healthy woman between 18 and 49 who has regular periods and uses or is willing to use these products.
Paris, Île-de-France RegionAges 18–49 - NCT07205003Recruiting
Artery stiffness test for memory disorders
This study looks at how the stiffness of your carotid artery (the main artery in your neck) relates to memory problems. It involves a brain MRI that you may already have planned, and results could help doctors better understand certain types of dementia.
RouenAges 70 years+ - NCT07207057RecruitingPhase 3
Platform trial testing multiple drugs for Parkinson's disease
This trial tests several experimental drugs at once to find new treatments for Parkinson's disease. If you have Parkinson's and take medication, you may be able to join and help speed up research.
LondonAges 30 years+ - NCT07210476Recruiting
Sleep screening tool for children with chronic conditions
This study tests a Turkish version of a sleep screening tool for children (ages 1 month to 18 years) with complex chronic conditions who were in a pediatric intensive care unit (PICU). It aims to help doctors assess sleep problems more easily.
IstanbulAges 1 month–18 years - NCT07211776RecruitingPhase 3
Study of ZL-1109 for active thyroid eye disease
This trial tests a new drug called ZL-1109 for people with active, moderate to severe thyroid eye disease (TED). It aims to see if the drug can reduce symptoms like bulging eyes and help patients feel better without using steroids.
BeijingAges 18–75 - NCT07213349RecruitingPhase 2
Daridorexant for Alzheimer's prevention
This study tests whether daridorexant, a medication that helps improve sleep, can prevent Alzheimer's disease. If you have mild memory concerns but not dementia, this trial may help find out if better sleep can protect your brain.
Montreal, QuebecAges 50–90 - NCT07213856Recruiting
Dietary help for constipation in Parkinson's disease
This study tests whether a special diet can help improve constipation symptoms in people with early-stage Parkinson's disease. It aims to see if changing what you eat can make bowel movements more regular and comfortable.
Porto Alegre, Rio Grande do SulAges 18 years+ - NCT07214727RecruitingPhase 1
A study of ALN-5288 for Alzheimer's disease
This trial tests an investigational drug called ALN-5288 for people with Alzheimer's disease. It aims to see if the drug is safe and how it affects the body.
MontrealAges 40–80 - NCT07214870RecruitingPhase 1
A study of a new medicine for liver disease in adults with extra body weight and liver fat
This trial tests a potential new medicine (NNC4005-0001) for liver disease in adults who have extra body weight and excess fat in their liver. It aims to see if the medicine can help improve liver health.
Montreal, QuebecAges 18–69 - NCT07216014RecruitingPhase 4
IL-23 antibody for inflammatory bowel disease
This trial tests a new antibody drug (IL-23 inhibitor) for people with Crohn's disease or ulcerative colitis. It aims to see if the drug is safe and effective. You may be able to join if you have moderate to severe disease and have not had certain bowel surgeries or infections.
Guangzhou, GuangdongAges 18–65 - NCT07216066RecruitingPhase 1
Study of ALN-SNCA for early Parkinson's disease
This trial tests a new experimental drug called ALN-SNCA, given as an injection into the spinal fluid, for people with early Parkinson's disease. The goal is to see if it is safe and well-tolerated.
Montreal, QuebecAges 50–80 - NCT07216976Recruiting
Adaptive DBS for personalized Parkinson's therapy
This study tests a new feature in your Medtronic DBS device that automatically adjusts stimulation based on brain signals. It aims to improve symptom control for people with Parkinson's disease.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07223944RecruitingPhase 3
Gene therapy trial for Gaucher disease type 1
This trial tests a gene therapy called FLT201 for adults with Gaucher disease type 1. It aims to provide a long-term treatment option for people who have been stable on enzyme replacement therapy (ERT) or substrate reduction therapy (SRT) for at least two years.
Los Angeles, CaliforniaAges 18 years+ - NCT07224607Recruiting
Light therapy for early Alzheimer's disease
This study tests a type of light therapy (called transcranial photobiomodulation) to see if it can help people with early-stage Alzheimer's. It involves coming to Cedars-Sinai for weekly sessions over a period of time.
Los Angeles, CaliforniaAges 55–89 - NCT07230847Recruiting
Healing of drug-coated vs. standard stents in high-bleeding-risk patients
This trial compares two types of stents (a drug-coated stent and a standard drug-eluting stent) in people with acute coronary syndrome who also have a high risk of bleeding. It uses a special camera to look at how the artery heals one month after the stent is placed.
Beijing, Beijing MunicipalityAges 18 years+
Hear when a new Neurological Diseases or Conditions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neurological diseases or conditions?
- Yes. Clin2 currently lists 4,615 recruiting neurological diseases or conditions studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neurological diseases or conditions trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neurological diseases or conditions trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.